POM-V Prescription Required Companion Animal

Inflacam 0.5 mg Oral Suspension for Cats

Active ingredient: Meloxicam

Form

Liquid

Species

Cats

Manufacturer

Chanelle Pharmaceuticals Manufacturing Ltd

VMD MA No.

08749/5008

What it's used for

Alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders in cats.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Inflacam 0.5 mg Oral Suspension for Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders in
cats.

Post-operative pain and inflammation following surgical procedures:
After initial treatment with Inflacam 5 mg/ml solution for injection for cats, continue
treatment 24 hours later with Inflacam 0.5 mg/ml oral suspension for cats at a dosage
of 0.05 mg meloxicam/kg body weight (0.1 ml /kg). The oral follow-up dose may be
administered once daily (at 24-hour intervals) for up to four days.
Acute musculo-skeletal disorders:
Initial treatment is a single oral dose of 0.2 mg meloxicam/kg body weight (0.4 ml/kg)
on the first day. Treatment is to be continued once daily by oral administration (at 24-
hour intervals) at a dose of 0.05 mg meloxicam/kg body weight (0.1 ml/kg) for as long
as acute pain and inflammation persist.
Chronic musculo-skeletal disorders:
Initial treatment is a single oral dose of 0.1 mg meloxicam/kg body weight (0.2 ml/kg)
on the first day. Treatment is to be continued once daily by oral administration (at 24-
hour intervals) at a maintenance dose of 0.05 mg meloxicam/kg body weight (0.1 ml
/kg). A clinical response is normally seen within 7 days. Treatment should be
discontinued after 14 days at the latest if no clinical improvement is apparent.
Route and method of administration
A one ml syringe is provided with the product. The precision of the syringe is not
suitable for the treatment of cats below 1 kg.
Shake well before use. To be administered orally either mixed with food or directly into
the mouth.
To ensure a correct dosage, body weight should be determined as accurately as
possible.
The use of suitably calibrated measuring equipment is recommended.
Avoid introduction of contamination during use.

Do not use in pregnant or lactating animals.
Do not use in cats suffering from gastrointestinal disorders such as irritation and
haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Do not use in case of hypersensitivity to the active substance or to any of the
excipients.
Do not use in cats less than 6 weeks of age.

Cats:
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Appetite loss, Lethargy.
Vomiting, Diarrhoea, Blood in faeces
1,
Gastric ulcer, Small intestine ulcer, Large
intestine ulcer.
Elevated liver enzymes.
Renal failure.
occult
These side effects are in most cases transient and disappear following termination of
the treatment but in very rare cases may be serious or fatal.
If adverse reactions occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See also the package leaflet for
respective contact details.

None.

Special precautions for safe use in the target species:
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a
potential risk of renal toxicity.
Post-operative pain and inflammation following surgical procedures:
In case additional pain relief is required, multimodal pain therapy should be considered.
Chronic musculoskeletal disorders:
Response to long-term therapy should be monitored at regular intervals by a veterinary
surgeon.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
People with known hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs)
should avoid contact with the veterinary medicinal product.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.

Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances
with high protein binding may compete for binding and thus lead to toxic effects. The
veterinary medicinal product must not be administered in conjunction with other
NSAIDs or glucocorticosteroids. Concurrent administration of potential nephrotoxic
veterinary medicinal products should be avoided.
Pre-treatment with anti-inflammatory substances may result in additional or increased
adverse effects and accordingly a treatment-free period with such veterinary medicinal
products should be observed for at least 24 hours before commencement of treatment.
The treatment-free period should however take into account the pharmacological
properties of the veterinary medicinal products previously used.

This veterinary medicinal product does not require any special storage conditions.

Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.